3-nitropropionic acid has been researched along with glutathione disulfide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beal, MF; Calingasan, NY; Cormier, K; Ferrante, RJ; Smith, K; Wille, EJ; Yang, L | 1 |
| Gopinath, K; Sudhandiran, G | 1 |
2 other study(ies) available for 3-nitropropionic acid and glutathione disulfide
| Article | Year |
|---|---|
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 8-Hydroxy-2'-Deoxyguanosine; alpha-Synuclein; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Creatine; Deoxyguanosine; Disease Models, Animal; Dopamine; Drug Therapy, Combination; Glutathione; Glutathione Disulfide; Huntington Disease; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitro Compounds; Parkinson Disease; Propionates; Rats; Rats, Inbred Lew; Tyrosine 3-Monooxygenase; Ubiquinone | 2009 |
Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway.
Topics: Administration, Oral; Analysis of Variance; Animals; Convulsants; Corpus Striatum; Cyclooxygenase 2; Disease Models, Animal; Down-Regulation; Encephalitis; Flavanones; Glutathione; Glutathione Disulfide; Hydrogen Peroxide; Hydroxyl Radical; Male; Microscopy, Electron, Transmission; NAD(P)H Dehydrogenase (Quinone); Neurodegenerative Diseases; Neuroprotective Agents; NF-E2-Related Factor 2; Nitric Oxide Synthase Type II; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha | 2012 |